Observational Study on Treatment of Metastatic Colorectal Cancer and the Role of K-Ras
NCT ID: NCT01651013
Last Updated: 2023-03-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
500 participants
OBSERVATIONAL
2010-10-31
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
RAS Mutation Testing in the Circulating Blood of Patients With Metastatic Colorectal Cancer
NCT02502656
Micrometastasis in Gastrointestinal Cancer
NCT01919151
Second Look Laparoscopy in Colorectal Cancer
NCT01628211
Exploratory Study in Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver Metastases
NCT01834014
Circulating Tumor Cells in mCRC for Liver Resection
NCT03295591
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
metastatic colorectal cancer
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Metastatic disease
* Signed informed consent
Exclusion Criteria
* Refusal or incapability of providing informed consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute, Naples
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
R. V. Iaffaioli, M.D.
Role: PRINCIPAL_INVESTIGATOR
National Cancer Institute, Naples
G. Nasti, M.D.
Role: PRINCIPAL_INVESTIGATOR
National Cancer Institute, Naples
M. C. Piccirillo, M.D.
Role: PRINCIPAL_INVESTIGATOR
National Cancer Institute, Naples
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
A.O.G. Rummo
Benevento, , Italy
Istituto Nazionale dei Tumori , Oncologia Medica - Dipartimento Entero-proctologico
Napoli, , Italy
Ospedale Civile Umberto I
Nocera Inferiore, , Italy
C:R.O. Regione Basilicata Ospedale Giustino Fortunato
Rionero in Vulture, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CALLAS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.